Next, we selected the most differentially expressed genes ENO2, ENO3, ALDOC, and ACSS2 from the Glycolysis/Gluconeogenesis pathway according to the sequencing analysis results, and verified their mRNA expression in USP21 knockdown and overexpression CCA cells by RT-qPCR. The gene discussed is ACSS2; the disease is cholangiocarcinoma.